Acumen Pharmaceuticals Inc (ABOS) stock news · rev $10.8M
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
This ABOS news page leads with what Acumen Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ABOS yet. We will not pad this page with generic market recap.
Latest reported ABOS revenue for 2023-12-31 was $10.8M. Net income was -$52.4M. Revenue was up 351.1% from 2022-12-31 to 2023-12-31. ABOS currently screens at market cap $73.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABOS stock page; for the tape open the quote page.
ABOS stock news FAQ
What are ABOS's latest revenue and net income?
Latest cached Acumen Pharmaceuticals Inc (ABOS) revenue for Dec 31, 2023 was $10.8M. Net income was -$52.4M. Statements: https://lician.com/financials/abos
How did ABOS revenue change from the prior cached period?
Cached Acumen Pharmaceuticals Inc (ABOS) revenue was up 351.1% from $2.4M (Dec 31, 2022) to $10.8M (Dec 31, 2023). Statements: https://lician.com/financials/abos
What is ABOS's market cap?
Acumen Pharmaceuticals Inc (ABOS) market cap is $73.3M on the latest cached fundamentals snapshot.
What kind of company is ABOS?
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
Where is ABOS stock news listed?
Cached stock news for Acumen Pharmaceuticals Inc (ABOS) is listed at https://lician.com/news/abos. Filings: https://lician.com/sec/abos
Not investment advice.